Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment

Journal of Clinical Epidemiology

Volumn 50, Issue 4, 1997, Pages 401-410

  Zucker, D R ^a   Schmid, C H ^a   McIntosh, M W ^b   D'Agostino, R B ^c   Selker, H P ^a   Lau, J ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Boston University   (United States)

Author keywords

'Meta analysis'; Bayesian; Effectiveness; Hierarchical; N of 1

Indexed keywords

AMITRIPTYLINE;

ARTICLE; BAYES THEOREM; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; FIBROMYALGIA; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BAYES THEOREM; CHRONIC DISEASE; CROSS-OVER STUDIES; FIBROMYALGIA; HUMANS; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0030913882     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00429-5     Document Type: Article

References (28)

1. Cochrane AL. Effectiveness and Efficiency: Random Reflections on Health Services, London: Nuffield Provincial Hospitals Trust; 1972.
2. Barlow DH, Hersen M. Single Case Experimental Designs: Strategies for Studying Behavior Change, 2nd Ed. Oxford, New York: Pergamon Press; 1984.
3. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy - Randomized trials in individual patients. N Engl J Med 1986; 314: 889-892.
4. Louis TA, Lavori PW, Bailar JC, Polansky M. Crossover and self-controlled designs in clinical research. N Engl J Med 1984; 310: 24-31.
5. Senn S. Cross-Over Trials in Clinical Research. Chinchester, New York: J Wiley; 1993.
6. Edgington, E. Statistics and the single case analysis. Prog Behavior Modification 1984; 16: 83-119.
7. Guyatt GH, Keller JL, Jaeschke R, Rosenhloom D, Adachi JA, Newhouse, MT. The n-of-1 randomized controlled trial: Clinical usefulness: Our three-year experience. Ann Intern Med 1990; 112: 293-299.
8. Larson EB, Ellsworth AJ, Oas J. Randomized clinical trials in single patients during a 2-year period. JAMA 1993; 270: 2708-2712.
9. March L, Irwig L, Schwartz J, Simpson J, Chock C, Brooks P. n Of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. Br Med J 1994; 309: 1041-1046.
10. Kleveland PM, Larsen S, Sandvik L, Kristensen P, Johannessen T, Hafstad PE, Sandhakken P, et al. The effect of cimetidine in non-ulcer dyspepsia: Experience with a multi-cross-over model. Scand J Gastroenterol 1985; 20: 19-24.
11. Jaeschke R, Adachi J, Guyatt O, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991; 18: 447-451.
12. Larson EB. N-of-1 clinical trials: A technique for improving medical therapeutics. West J Med 1990; 152: 52-56.
13. Guyatt GH, Heyting A, Jaeschke R, Keller J, Adachi JD, Roberts R. N of 1 randomized trials for investigating new drugs. Controlled Clin Trials 1990; 11: 88-100.
14. Guyatt G, Sackett D, Adachi J, Robin R, Chong J, Rosenbloom D, Keller J. A clinician's guide for conducting randomized trials in individual patients. Can Med Assoc J 1988; 139: 497-503.
15. Edgington ES. Statistics and single case analysis. Prog Behav Modif 1984; 16: 83-119.
16. Spiegelhalter DJ. Statistical issues in studies of individual response. Scand J Gastroenterol 1988; 23: 40-45.
17. DuMouchel W. Documentation for Hierarchical Bayes Linear Model Program. New York: Columbia University Department of Medical Informatics; 1995.
18. Jaeschke R, Singer J, Guyatt G. Measurement of health status: Ascertaining the minimally clinically important difference. Controlled Clinical Trials 1989; 10: 407-410.
19. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in disease specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.
20. Juniper EF, Guyatt OH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with Asthma. Qual Life Res 1996; 5: 35-46.
21. DuMouchel W. Bayesian metaanalysis. In: Berry DA, Ed. Statistical Methodology in the Pharmaceutical Sciences. New York: Marcel Dekker; 1990: pp. 509-529.
22. DuMouchel W, Watemaux C. Discussion to Morris CN, Normand SL. Hierarchical Models for Combining Information and for Meta-Analyses. In: Bernardo, JM, Berger JO, Dawid AP, Smith AFM, Eds. Bayesian Statistics 4. Oxford: Clarendon Press; New York: Oxford University Press; 1992.
23. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fihromyalgia. Arthritis Rheum 1986; 29: 1371-1377.
24. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blinded clinical trial. Arthritis Rheum 1994; 37: 32-40.
25. D'Agostino R, Kwan H. Measuring effectiveness: What to expect without a randomized control group. Med Care 1995; 33(Suppl.) AS95-AS105.
26. Irwig L, Glasziou P, March L. Ethics of N-of-1 trials. Lancet 1995; 345: 469.
27. Greenfield S, Kaplan S, Ware JE, Yano EM, Frank HJL. Patient's participation in medical care: Effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 1988; 3: 448-457.
28. Mahon J, Laupacis A, Donner A, Wood T. Randomised study of n of 1 trials versus standard practice. Br Med J 1996; 312: 1069-1074.